SCHEMBL8094069

SCHEMBL8094069

Cc1csc(C(C=O)=C(c2ccc(F)cc2)N(C)C)c1

nearest known ligand 0.38

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
KDR P35968 3/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
HTR7 P34969 1/20 0.31
GRM1 Q13255 2/20 0.31
POLB P06746 1/20 0.31
MAOA P21397 2/20 0.31
MAOB P27338 2/20 0.31
ATM Q13315 1/20 0.30
KCNMA1 Q12791 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9634784 0.81 TCF4 (0.41) DAOCYP1A2CYP2C19MEN1KMT2A
SCHEMBL7087792 0.72 CES2 (0.53) DAOCYP1A2CYP2C19MEN1KMT2A
SCHEMBL8093355 0.72 CYP1A2 (0.42) DAOCYP1A2CYP2C19MEN1KMT2A
SCHEMBL5788690 0.71 LTA4H (0.49) CYP1A2CYP2C19MEN1KMT2ASMN1; SMN2
SCHEMBL8094065 0.70 LMNA (0.40) CYP1A2CYP2C19MEN1KMT2A
SCHEMBL8094061 0.70 LMNA (0.40) CYP1A2CYP2C19MEN1KMT2A
SCHEMBL10968608 0.68 DAO (0.36) DAOCYP1A2CYP2C19MEN1KMT2A
SCHEMBL6643910 0.64 DAO (0.47) DAOCYP2C19KMT2ASMN1; SMN2POLB
SCHEMBL10274823 0.64 DAO (0.61) DAOKDRSMN1; SMN2
SCHEMBL3047680 0.64 DAO (0.61) DAOKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0808304-B1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2000-12-27 EP disclosed
US-5916905-A ANTIARTHRITIC AGENTS; ANALGESICS; ANTIPYRETICS G. D. SEARLE & CO. (US) 1999-06-29 US disclosed
US-5686470-A 2, 3-substituted pyridines for the treatment of inflammation WEIER RICHARD M (US) 1997-11-11 US disclosed